Physician profile
Keith Mankowitz
NPI 1598783938
$16,478.87
in general payments reported to CMS, 2019-2025
51 companies · $2,414 in 2025
The $2,414 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,031 · 2020: $327 · 2021: $831 · 2022: $1,424 · 2023: $1,675 · 2024: $1,776 · 2025: $2,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,680 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,680.30 |
| Education | $184.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $5,624.03 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $1,322.31 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,209.53 | 2019-2025 | Evkeeza, Praluent |
| Amgen INC. | $924.63 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $846.68 | 2019-2025 | Watchman Access System, Watchman Flx |
| Merck Sharp & Dohme LLC | $600.20 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $557.28 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $543.36 | 2020-2025 | Farxiga, Andexxa, Wainua |
| Pfizer INC. | $534.35 | 2019-2025 | |
| Novo Nordisk INC | $424.61 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $354.24 | 2019-2022 | |
| Esperion Therapeutics, INC. | $337.91 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $331.26 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $281.47 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.34 | 2019-2025 | Jardiance |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $217.12 | 2022-2025 | Onpattro |
| Akcea Therapeutics, INC. | $210.35 | 2019-2021 | |
| American Regent | $174.60 | 2025 | Injectafer |
| Heartflow, INC. | $171.03 | 2024-2025 | |
| Lundbeck LLC | $167.36 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $134.16 | 2022-2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $89.44 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, Ltd. | $82.97 | 2022-2023 | Arcalyst |
| Cvrx, INC. | $82.47 | 2023-2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $72.63 | 2022-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $71.00 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $60.25 | 2022-2024 | Optimizer, Optimizer |
| Philips North America LLC | $58.77 | 2019-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided |
| Lilly USA, LLC | $57.72 | 2025 | Zepbound, Mounjaro |
| Preventice Services, LLC | $56.61 | 2019 | |
| Abbott Laboratories | $53.28 | 2023 | Jot Dx, Confirm Rx |
| Genzyme Corporation | $47.13 | 2019-2023 | |
| Daiichi Sankyo INC. | $44.35 | 2019-2024 | Injectafer |
| Abiomed | $41.79 | 2023 | Impella |
| Edwards Lifesciences Corporation | $40.07 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $35.25 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $32.99 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $31.00 | 2025 | Edarbi |
| Csl Behring | $30.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $25.75 | 2021-2022 | |
| Aegerion Pharmaceuticals, INC. | $25.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $23.52 | 2019-2020 | |
| Inari Medical, INC. | $21.94 | 2022 | |
| Glaxosmithkline, LLC. | $20.71 | 2025 | Arexvy |
| Zoll Circulation INC | $20.47 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Irhythm Technologies, INC. | $20.16 | 2023 | Zio Xt Patch |
| Vital Connect, INC | $20.10 | 2024 | Vitalpatch Rtm |
| Portola Pharmaceuticals, LLC | $18.72 | 2019 | |
| Amryt Pharma Holdings Ltd | $17.31 | 2021 | |
| Medicure Pharma INC. | $16.79 | 2023 | Zypitamag |
| Hikma Pharmaceuticals USA | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Mankowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.